BJ-001

DB18585InvestigationalProtein Based Therapies

BJ-001 is a recombinant human interleukin-15/IL-15 receptor alpha complex with linked integrin-binding motif.

Mechanism: Pharmacologically active on Integrin beta-3, Integrin alpha-V, and Integrin beta-6
Curator reviewed
Code names: BJ-001

Resolves to

Targets

What you can answer from here — as of July 09, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with BJ-001, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.